No Data
No Data
Watching Dyadic International; Zacks Small-Cap Research Gives Stock $9 Price Valuation
Watching Dyadic International; Zacks Small-Cap Research Gives Stock $9 Price Valuation
Dyadic Dips on New Partnership With Proliant
Dyadic International, Inc. and Proliant Health and Biologicals Announce Recombinant Albumin Development and Commercialization Partnership
JUPITER, Fla., June 28, 2024 — Dyadic International, Inc. ("Dyadic") (NASDAQ: DYAI), announced today that they have entered into a development and commercialization partnership with Proliant Health
Form 144 | Dyadic(DYAI.US) 10% Stockholder Proposes to Sell 657.9K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 6, $Dyadic(DYAI.US)$ 10% Stockholder Francisco Trust under agreement dated February 28, 1996 intends to sell 292.4K shares of its common stock on Jun 6, with a total market
Dyadic to Attend Industry Events in June
JUPITER, Fla., May 30, 2024 — Dyadic International, Inc. ("Dyadic", or the "Company") (NASDAQ: DYAI), a biotechnology company focused on the efficient large-scale manufacture of proteins for use in
Earnings Call Summary | Dyadic(DYAI.US) Q1 2024 Earnings Conference
The following is a summary of the Dyadic International, Inc. (DYAI) Q1 2024 Earnings Call Transcript:Financial Performance:Dyadic International closed a $6 million convertible note financing in the fi